Create a Report

Please provide report title
Please provide location
Please provide details

Add more

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Drop files here
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!

The report was
successfully sent!


Your report is queued - it may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Recall notice

Actylis Lithium Orotate products recalled due to Incorrect Concentration Levels, USA

5 months ago source accessdata.fda.gov

United States

Aceto US, L.L.C. has initiated a voluntary recall of its Actylis brand Lithium Orotate products due to incorrect concentration levels. The products were distributed across several states, including New Jersey, North Carolina, California, Utah, Montana, Florida, Arizona, and New York in the United States.

AFFECTED PRODUCTS:

PRODUCT: Actylis brand Lithium Orotate 4%
- Packaged in: HDPE Liner in a 25kg carton
- SKU: TLIOR0104
- Lot: T250464; T250265; T250184; T240967; T240619; T240452; T240346; T230944; T20230304
- Product Quantity: 4,485.95 Kg
- Reason for recall: 4% Lithium Orotate product may only contain 3%

PRODUCT: Actylis brand Lithium Orotate 9%
- Packaged in: HDPE Liner in a 25kg carton
- SKU: TLIOR0109
- Lot: T250409; T250353; T250310; T250124; T241240; T240936; T240560; T240125; T20230223; T20230403; T20220701; T20221002; T20221204
- Product Quantity: 6,033.45 Kg
- Reason for recall: 9% Lithium Orotate product may contain 4.45%

The issue was discovered through internal quality checks. This recall is classified as Class III and was initiated on June 24, 2025, with the classification date on August 8, 2025. The recall is currently ongoing.

Source: www.accessdata.fda.gov/scripts/ires/index.cfm

#recall #unitedstates

Recent Reports Near Me